Michel Sadelain, MD, PhD
Michel Sadelain, MD, PhD, is a physician scientist at Memorial Sloan Kettering Cancer Center (MSKCC) whose lab studies the mechanisms governing transgene expression, stem cell engineering, and genetic strategies to enhance immunity against cancer. He is the director of the MSKCC Center for Cell Engineering (CCE), which aims to foster cutting-edge research on emerging cellular therapies for the treatment of cancer, genetic disorders, infectious diseases, and degenerative disorders. The CCE brings together researchers who investigate adoptive T cell therapies, bone marrow and cord blood transplantation, human stem cell biology, and the transfer, regulation and repair of genes in human cells. This unique physician-scientist partnership comprises researchers from both Memorial Hospital and the Sloan Kettering Institute who strive to devise and implement breakthrough therapies for cancer and allied diseases.
DatesMarch 14, 2023
LocationMahley Auditorium & Online
AudienceGladstone and UCSF
The Gladstone-UCSF Institute of Genomic Immunology Seminar Series showcases speakers at the intersection of genomic technology and immunology research with an aim to engineer the human immune system for therapeutic benefit. Speakers span technology development, synthetic biology, bioengineering, and the development and clinical application of immunotherapy. These talks are open to the Gladstone and UCSF communities.
Diversity, Equity, and Inclusion
At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.
We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.